The Food and Drug Administration (FDA) has approved Zurnai ™, the first nalmefene HCl autoinjector for the emergency treatment of known or suspected opioid overdose in adults an ...
Opioid agonists are the gold standard for the treatment of OUD but have not been able to solve the opioid crisis.
The FDA approved the first over-the-counter drug, naloxone nasal spray, last year to help reduce drug overdose deaths.
The pharma is seeking full approval for its anticoagulation reversal drug Andexxa, which the FDA granted accelerated approval ...
Protonitazene, a synthetic opioid three times stronger than fentanyl, was connected to an overdose in Stevenson Ranch. Dealer ...
A recent study by North Carolina State University exposes a critical shortfall in opioid treatment availability within the ...
AstraZeneca has ended work on an opioid use disorder (OUD) drug after the orexin 1 receptor antagonist demonstrated a ...
New litigation centered on increasing access to substance-use disorder treatment in jails and prisons is helping to reduce ...
Intellia Therapeutics received the FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for nexiguran ziclumeran ...
Seven months ago, Cindy Jacquet came home after running errands with her daughter to find her son's car parked in front of ...
Vertex expects to hear from the FDA by the end of January if suzetrigine will be approved ... albeit not more so than a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback